baber/WOPTO huggingface dataset:
Patent NZ-289118-A (NZ)
Title: 1,2,4-triazol-3-yloxymethylene-anilide derivatives, intermediates thereof
Inventor: MULLER BERND
IPC: C07C239/08
Filed: 1995-06-21
Abstract: 2-[1',2',4'-Triazol-3'-yloxymethylene]anilides of the formula Iwhere the index and the substituents have the following meanings:n is 0, 1, 2, 3 or 4;X is a direct bond, O or NRa;Ra is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl;R1 is nitro, cyano, halogen, unsubstituted or substituted alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy or alkynyloxy;R2 is hydrogen, nitro, cyano, halogen, alkyl, haloalkyl, alkoxy, alkylthio or alkoxycarbonyl;R3 is unsubstituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl;R4 is hydrogen, unsubstituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkylcarbonyl or alkoxycarbonyl;R5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl,processes and intermediates for their preparation and their use are described.
Patent NZ-293022-A (NZ)
Title: Electric fence with multistrand stretchable conductive wire
Inventor: NORDBERG FRED
IPC: H05C1/04
Filed: 1995-09-08
Abstract: PCT No. PCT/SE95/01012 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/08140 PCT Pub. Date Mar. 21, 1996An electric fence has a series of posts connected by an elastically-stretchable, electrically-conductive string to form an enclosure for animals. The string has a unique structure which is comprised of electrically conductive and electrically nonconductive threads intertwined around a rubber core material. The threads are braided in such a way that the string may be substantially stretched without the braided threads severing. The elastically-stretchable construction prevents the string from breaking when moving animals collide with the electrified string.
Patent NZ-306974-A (NZ)
Title: Electrophoretic cassette with ion exchange driving source
Inventor: CABILLY SHMUEL
IPC: G01N27/447
Filed: 1996-04-26
Abstract: A cassette (10) for conducting therein electrophoresis separation which includes a closed chamber (11), the chamber includes therein a body of gel (18), means (20,22) for providing ions for driving the electrophoresis separation and electrodes (24,26) for connecting the cassette (10) to an external electrical power source, thereby enabling to drive the electrophoresis separation. <IMAGE>
Patent NZ-502061-A (NZ)
Title: Multi-layered piezoelectric ceramic transformers
Inventor: BISHOP RICHARD PATTEN
IPC: H01L41/107
Filed: 1998-05-26
Abstract: A multi-layer piezoelectric transformer device (1) includes first and second electroactive members (30, 48) having electrodes (32, 38, 46, 50) bonded to each of their opposing major faces; and a bonding layer (34, 40, 44, 52) disposed in-between. The first and second electroactive members (30, 48) are polarized in a thickness direction, between their two major faces, such that when energized by an electric field the first and second electroactive members (30, 48) longitudinally strain. The first and second electroactive members (30, 48) are arranged such that deformation of one electroactive member (30) results in corresponding deformation of the other electroactive member (48). The device provides substantial transformation ratios in which relatively high power may be transferred in relation to the size of the unit, operability over wide input and output frequency bandwidths, and electrical isolation of the voltage and current at the input to the device from the voltage and current at the output of the device.
Patent NZ-503566-A (NZ)
Title: Sequential separation of whey proteins, an infant formula formulation and a fat substitute
Inventor: MIRANDA QUIRINUS
IPC: A23C9/14
Filed: 1997-09-22
Abstract: A method is disclosed for sequential separation of whey proteins using radial-flow chromatography. Different buffer systems adjusted to suitable pH and ionic strength are utilised in the separation process. The method separates at least five different proteins from whey. Infant feeding formulas, and other food formulations are also disclosed incorporating therein in different proportions various proteins separated from the whey.
Patent NZ-512828-A (NZ)
Title: Benzenic sulphonamide derivatives and their uses
Inventor: DELARGE JACQUES
IPC: A61K31/64
Filed: 2000-01-12
Abstract: Described are benzene-sulphonamide derivatives having the general formula (I), wherein: X represents a nitro, cyano or halogen group, Y1 represents a secondary or tertiary amino group, a sulphur or an oxygen, Y2 represents a -NH group or a nitrogen, Z represents oxygen, sulphur, -N-CN or -CH-NO2, and R1 and R2, which can be identical or different, represent each independently a saturated or unsaturated, linear or branched C2-C12 alkyl group, a saturated or unsaturated C3-C12 alicyclic group, an aryl group optionally substituted by C1-C4 alkyl, nitro, cyano, trifluoromethyl, carboxy and halogen, or an arylalkyl group, or R1 and/or R2 form with Y1 and/or Y2 a saturated or unsaturated 5 to 7 membered heterocyclic group, with the exception of derivatives for which X is a nitro group, Y1 represents a secondary amine group (-NH-), Y2 represents a -NH group, Z an oxygen, R2 an isopropyl and R1 an element selected in a group consisting of (m-toluyl, phenyl and cyclooctyl) and with the exception of N-[(cyclooctylamino-5-cyanobenzene)sulphonyl]-N'-isopropyl urea. Also described is the use of compounds of formula (I) in pharmaceutical preparations for the treatment of illnesses involving the thromboxan A2.
Patent NZ-514032-A (NZ)
Title: Device for sampling liquids
Inventor: SUTTON ROSEMARY
IPC: B01L3/00
Filed: 2000-03-10
Abstract: A device is disclosed for sampling liquids, especially blood. The device includes a first side (1), a second side (2) secured to the first side at a corresponding end of each side, and a piece of absorbent material (3) secured between each side. The first and second sides have fold lines (5) adjacent to the corresponding end of each side so that each may be folded back to an open position to form a handle and expose the absorbent material. The device may then be returned to a closed position in which the absorbent material is substantially enclosed by the first and second sides.
Patent NZ-521518-A (NZ)
Title: Compositions and methods for treatment of epilepsy
Inventor: MARGOLIN SOLOMON B
IPC: A61K31/445
Filed: 2000-02-21
Abstract: Use of N-phenyl substituted 2-pyridone compound and/or pharmaceutically acceptable salts thereof that have anticonvulsant (anti-epileptic) properties for treating a mammal with an epileptic condition is disclosed.
Patent NZ-525511-A (NZ)
Title: Methods of modifying eukaryotic cells
Inventor: ECONOMIDES ARIS N
IPC: A01K67/027
Filed: 2001-10-31
Abstract: A method for genetically modifying an endogenous gene or chromosomal locus of interest in eukaryotic cells, comprising: (a) obtaining a large cloned genomic fragment greater than 20 kb containing a DNA sequence of interest; (b) using bacterial homologous recombination to genetically modify the large cloned genomic fragment of (a) to create a large targeting vector for use in the eukaryotic cells (LTVEC); the LTVEC having homology arms which total greater than 20 kb; (c) introducing the LTVEC of (b) into the eukaryotic cells to modify by homologous recombination the endogenous gene or chromosomal locus in the cells; and (d) using a quantitative assay to detect modification of allele (MOA) in the eukaryotic cells of (c) to identify those eukaryotic cells in which the endogenous gene or chromosomal locus has been genetically modified.
Patent NZ-531008-A (NZ)
Title: Electrically isolated module
Inventor: PRIVETT ZOLIE W
IPC: H01H9/52
Filed: 2002-08-09
Abstract: An electronic module 18 adapted to be located within the housing of an AC power tool that uses a portion of the housing as a heat sink is disclosed. The module includes a power device 38 connected to a line voltage source, the power device 38 having an external tab 42, and a thermal pad 40 placed between the external tab and the tool housing. The power device provides a first layer of electrical insulation between the tab and the line voltage source and the thermal pad provides a second layer of insulation between the tab and the housing. These two layers of electrical insulation provide a predetermined amount of insulation between the line voltage and the tool housing while allowing the housing to function as a heat sink to dissipate heat developed by the power device 38.
Patent NZ-533870-A (NZ)
Title: Trailer with selective elevating and lowering feature
Inventor: SHANAHAN ROBERT
IPC: B60P1/02
Filed: 2002-12-11
Abstract: A wheeled transport vehicle includes a frame with two slidably interconnected frame members. A tongue projects from one of the members and is operable to move one of the frame members between extended and retracted positions. Wheel mounting members are pivotally connected to the frame. Mechanical linkage interconnecting the wheel mounting members and the tongue result in raising or lowering of the trailer frame. Stabilizers and locks are utilized to maintain trailer stability.
Patent NZ-534388-A (NZ)
Title: Delta1-pyrrolines and their use as pest control agents
Inventor: FUSSLEIN MARTIN
IPC: C07D413/10
Filed: 2003-01-21
Abstract: Delta1-pyrrolines of formula (I) that are suitable for use as pesticides are disclosed, wherein R1, R2, R3, R4, R5, R6, X, Y, R7, R8 and R9 are defined as per the description. Methods for producing these pyrrolines and the use thereof for controlling pests, as well as intermediate products and methods for producing those intermediate is also disclose.
Patent NZ-535096-A (NZ)
Title: Pouch for collecting human waste
Inventor: FALCONER MALCOLM
IPC: A61F5/445
Filed: 2003-07-04
Abstract: A drainable pouch for collecting human waste having an outlet through which the pouch contents may be drained. The pouch is folded from an extended position to a retracted position. A fastener secures the outlet in itÆs retracted position and is a peelable mechanical engagement fastener with first and second parts being plastic extrusions. (62) Divided Out of 526872
Patent NZ-537497-A (NZ)
Title: Aqueous resin dispension for floors, and floor polish using same
Inventor: KOKETSU AKEMI
IPC: C09G1/16
Filed: 2003-07-17
Abstract: Disclosed herein is an aqueous resin dispersion for floors in which a copolymer comprising the monomer units (a), (b), and (c) as the structural units is dispersed in water, wherein the content ratios of each monomer in said aqueous resin dispersion for floors, based on the total amount of all the monomers, are: (a) 1 to 70 wt.% vinyl monomer units with an alicyclic structure; (b) 5 to 50 wt.% vinyl monomer units with carboxyl groups; and (c) 5 to 90 wt.% non-aromatic vinyl monomer units other than (a) and (b) above; as well as a floor polish comprising the dispersion. This floor polish composition has an excellent gloss, black heel mark (BHM) resistance, scuff resistance, and storage stability, which in particular has removability, adhesive properties, stain resistance, and water resistance, which uses no aromatic vinyl monomers in an aqueous resin dispersion for floors and thus has no effects such as sick house syndrome, and which also uses no metal crosslinking and is thus excellent in environmental safety.
Patent NZ-542242-A (NZ)
Title: Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
Inventor: MANTLO NATHAN BRYAN
Filed: 2001-11-09
Abstract: Disclosed is a compound of formula I wherein: R1 is selected from H or optionally substituted alkyl, aryl-alkyl, heteroaryl-alkyl, cycloalkylaryl-alkyl, and -CH2-C(O)-R17-R18, wherein R17 is O or NH and R18 is optionally substituted benzyl; W is O or S; R2 is H or a optionally substituted alkyl, allyl, aryl-alkyl, heteroaryl-alkyl, sulphonamide, amide, OR10 and cycloalkyl, wherein R10 is as defined in the specification; X is an optionally substituted alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S; Y isC, O, S, NH or a single bond; and E is as defined in the specification. Compounds of the type disclosed are agonists of peroxisome proliferator activated receptor alpha and are useful in the treatment of disease such as diabetes mellitus, cardiovascular disease, obesity, syndrome X and gastrointestinal disease.
Patent NZ-544589-A (NZ)
Title: Method for wirelessly disabling a vehicle if being tampered with or if a payment is overdue
Inventor: SIMON MICHAEL P
IPC: B60R25/04
Filed: 2004-07-09
Abstract: A system and method for disabling a vehicle is disclosed. The method comprises the steps of: periodically sending a signal from a tamper transmitter to a temper receiver; determining whether the vehicle is being tampered with; inhibiting the periodic sending of the signal if it is determined that the vehicle is being tampered with; and disabling the vehicle if the periodic sending of the signal is inhibited, wherein the vehicle is disabled by sending a wireless signal from the tamper receiver to a relay in a power control panel of the vehicle, the relay inhibiting power to a critical system of the vehicle. The method disclosed may disable a vehicle due to attempted tampering or if a payment is not made on the vehicle prior to a payment due date.
Patent NZ-546806-A (NZ)
Title: Antisense IAP nucleobase oligomers and uses thereof
Inventor: LACASSE ERIC
IPC: A61K38/00
Filed: 2003-03-27
Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis and treat proliferative diseases.
Patent NZ-553596-A (NZ)
Title: Reduction of backwash liquid waste
Inventor: ZHA FUFANG
IPC: B01D65/02
Filed: 2005-09-07
Abstract: A method of filtering suspended solids from a liquid suspension comprises applying a pressure differential across walls of permeable hollow membranes 5 immersed in the liquid suspension flowed to and contained in a vessel 4, with the liquid suspension being applied to the outer walls of the membranes 5 to induce and sustain filtration through the membrane walls. Some of the suspension will pass through the membrane walls 5 and be collected as permeate, while the solids will be retained in or on the membrane walls 5 or as suspended solids in the liquid suspension outside the membrane walls 5. The vessel 4 is cleaned by first stopping the flow of suspension to the vessel 5, reducing the level of liquid in the vessel 4 to a predetermined level where the membranes are still immersed in the liquid solution, dislodging the solids retained on or in the membranes and finally removing the liquid containing the dislodged solids from the vessel 4. This method allows a longer membrane operation time.
Patent NZ-556730-A (NZ)
Title: Ceramic conveyor roll with metal end caps and its assembly
Inventor: GAUTIER DAVID
IPC: F27D3/02
Filed: 2006-02-21
Abstract: Conveyor rolls used in high temperature applications, and an end cap assembly for such rolls. The conveyor roll (1) comprises a) a ceramic spool (2), b) at each end (21 ,22) of the ceramic spool (2), an end cap (4) comprising a metal ferrule (41) and having a certain internal circumference adapted to fit over an end (21) of the ceramic spool; and c) interposed between each end of the ceramic spool and the end cap an open tolerance ring (3) of resilient metal having a plurality of circumferentially arranged corrugations. This conveyor roll can resist temporary overheat or blockage without damages.
Patent NZ-566546-A (NZ)
Title: Differentially protected orthogonal lanthionine technology
Inventor: HILLMAN JEFFREY D
IPC: C07K1/107
Filed: 2006-08-11
Abstract: The disclosure relates to a method of synthesizing an intramolecularly bridged polypeptide comprising at least one intramolecular bridge. The method comprising: a) coupling the free carboxy terminus of a differentially protected orthogonal intramolecular bridge of formula (I) to a solid support or to the free amino terminus of an amino acid or and wherein L1 represents covalently bound amino acid side chains, wherein D, E, and G are protecting groups and wherein the reaction conditions for the removal of protecting group D are different from those for the removal of the amino protecting group of the amino acids of the remainder of the polypeptide chain; b) removing protecting group E to form a free amino terminus; c) adding an amino-protected amino acid to the free amino terminus and then deprotecting the amino acid to yield a new free amino terminus d) removing protecting group G to form a free carboxy terminus; e) coupling the free carboxy terminus of d) to the free amino terminus; f) removing protecting group D to form a free amino terminus. Also disclosed is a method of synthesizing an intramolecularly bridged polypeptide comprising two intramolecular bridges, wherein the two intramolecular bridges form two overlapping ring, two rings in series, or two embedded rings, methods for synthesizing lantibiotics, including Nisin A and intramolecularly bridged polypeptides synthesized by the methods disclosed and differentially protected orthogonal lanthionines.
Patent NZ-568050-A (NZ)
Title: Morpholine type cinnamide compound
Inventor: KIMURA TEIJI
IPC: A61K31/5377
Filed: 2006-10-27
Abstract: Disclosed is a morpholine compound represented by the formula (I) or a pharmacologically acceptable salt thereof, wherein (a) R1, R2, R3 and R4 are the same or different and each represent a hydrogen atom or an alkyl group, X1 represents an alkylene group, wherein the alkylene group may be substituted with 1 to 3 hydroxyl groups or alkyl groups, wherein the alkyl groups may be substituted with 1 to 3 hydroxyl groups, or a cycloalkyl group formed by two alkyl groups together bonded to the same carbon atom of the alkylene group, Xa represents a methoxy group or a fluorine atom, Xb represents an oxygen atom and Ar1 represents an optionally substituted aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group. (b) Ar1-X1- represents a cycloalkyl group as defined in the specification (c) one of R1and R2 and one of R3 and R4 are the same or different and each represent a hydrogen atom or an alkyl group; the other of R1 and R2 and the other of R3 and R4 together with the carbon atoms to which they are respectively bonded, form a cycloalkyl group, wherein the cycloalkyl group may be optionally substituted. (d) Ar1-X1- and R4 together with the nitrogen atom to which Ar1-X1- is bonded and the carbon atom to which R4 is bonded, form a 4- to 8-membered nitrogen containing heterocyclic group that may be substituted as defined in the specification (e) R1 and R2 together with the carbon atom to which they are bonded, form a cycloalkyl group. (f) R3 and R4, together with the carbon atom to which they are bonded, form a cycloalkyl group. Also disclosed is a composition comprising the compound and the use of the compound in the production of a medicament to treat a disease caused by amyloid beta.
Patent NZ-568489-A (NZ)
Title: Ovulation cycle monitoring and management
Inventor: GILMOUR ROBERT
IPC: G01N33/558
Filed: 2006-10-24
Abstract: Provided is a method for determining ovarian activity in a mammal by means of estrogen metabolite and progesterone metabolite measurements, comprising: obtaining two or more urine samples from a mammalian female subject, wherein the two or more urine samples are collected at intervals of time from between about 2 to about 4 days, from about 2 to about 5 days, from about 2 to about 6 days, from about 2 to about 7 days, from about 2 to about 8 days, from about 2 to about 9 days, from about 2 to about 10 days, from about 2 to about 12 days, from about 2 to about 15 days, from about 2 to about 20 days, from about 2 to about 25 days, from about 2 to about 28, or from about 2 to about 30 days and further wherein each said urine sample is prepared by collecting urine from said female subject over a 3-12 hour time period and normalizing the urine sample to a constant volume per unit time; contacting an amount of said sample with a solid phase capture element, a first binding protein capable of binding an estrogen metabolite and a second binding protein capable of binding a progesterone metabolite; determining the excretion rate of said estrogen metabolite and said progesterone metabolite in said sample; and determining the ovarian activity of said female subject based upon the excretion rates of said estrogen metabolite and said progesterone metabolite, wherein the coefficient of variation of said determination is less than 10%, and wherein: a statistically significant rise in the estrogen metabolite excretion rate indicates the beginning of a fertility phase; an ovulation cycle peak in the estrogen metabolite excretion rate indicates the time frame for optimal fertility; biochemical proof of ovulation is provided by an increase in the rate of progesterone metabolite excretion above a PdG ovulation threshold, or a rate of progesterone metabolite excretion above a PdG fertility threshold marks an end of the fertility phase. Combined analysis of estrogen and progesterone metabolite measurements and display of results can also be made remotely by a communication network.
Patent NZ-569038-A (NZ)
Title: Methods for inducing apoptosis in a target cell using anti-icam-1 anti bodies
Inventor: FRENDEUS BJORN
IPC: C07K16/28
Filed: 2006-12-08
Abstract: Disclosed is an in vitro method of inducing apoptosis in a target cell comprising the steps: a. providing one or more target cells displaying the cell surface antigen, ICAM-1; b. providing one or more antibody molecules which selectively binds to cell surface ICAM-1 and, on binding ICAM-1, induces apoptosis of the target cell; and wherein the antibody has variable regions having the sequences of Figure 10 or functionally equivalent homologues thereof; c. exposing the target cells of (a) to the antibody molecules of (b) to induce apoptosis in the target cells. Also disclosed is an antibody molecule for use in the method of claim 1 which selectively binds to cell surface ICAM-1 and, on binding ICAM-1, induces apoptosis of the target cell; and wherein the antibody has variable regions having the sequences of Figure 10 or functionally equivalent homologues thereof. Further disclosed is the use of the antibody molecule in the manufacture of a medicament for the treatment and/or prevention of a disease requiring the destruction of a target cell.
Patent NZ-573205-A (NZ)
Title: A floor covering system with interlocking base elements that a top layer can be releasably attached to
Inventor: ANDERSON PAUL ANTHONY
IPC: E04F15/00
Filed: 2007-05-14
Abstract: A floor covering system (2) is disclosed. The system has at least two layers, one of which is a base layer made from a multitude of interlocking base elements (20). These elements have a multitude of raised hollow tubes (16) with tapering sides (17) on the upper surface. The other layer is a top covering layer (22) to which is attached a fabric backing layer (24) having a multitude of loops. In use the base elements are placed on a floor (4) with the tubes uppermost and the top covering layer with the loops lowermost placed on the base elements such that the loops engage around the tapering side surfaces of the tubes to releasably attach the two layers together. When required, such as for example, when the top covering layer is worn, the top covering layer can be removed from the base layer without having to also remove the base layer thereby allowing the floor covering layer to be readily replaced with a new floor covering layer. The top covering layer is preferably made from a vinyl material, and preferably has a simulated wooden appearance.
Patent NZ-573706-A (NZ)
Title: Antitumoral dihydropyran-2-one compounds
Inventor: MARTIN LOPEZ MA JESUS
IPC: C07D309/32
Filed: 2007-06-15
Abstract: Disclosed herein are dihydropyran-2-one compounds of formula (I), wherein the substituents are as defined within the specification, compositions comprising said compounds, process for their isolation from Lithoplocamia lithistoides, and use of said compounds in the treatment of cancer.